Ayushman Arogya Mandirs, Digital Health & Inclusive NHM Progress Highlighted in 17th CRM Findings

Date:

Share post:

The two-day 10th National Summit on Innovation and Inclusivity, organised under the National Health Mission (NHM), concluded with a strong emphasis on evidence-based reforms, inclusive healthcare delivery, and system-wide strengthening through the findings of the 17th Common Review Mission (CRM). Held from April 30 to May 1, the summit brought together States and Union Territories to showcase scalable best practices while aligning regional strategies with national healthcare priorities. 

The 17th CRM, conducted across 17 States in November 2025, highlighted notable progress in the operationalisation of Ayushman Arogya Mandirs, expansion of comprehensive primary healthcare, and growing adoption of digital health solutions under the Ayushman Bharat Digital Mission. Key improvements were observed in maternal and child healthcare, non-communicable disease screening, and teleconsultation platforms that are expanding access to underserved populations. 

Deliberations also identified critical priorities for the next phase of NHM reforms, including optimized human resource deployment, improved availability of essential drugs and diagnostics, stronger referral systems, and enhanced outreach in remote areas. The summit reaffirmed the government’s commitment to cooperative federalism, data-driven governance, and resilient public health systems designed to deliver equitable, affordable, and future-ready healthcare for all. 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Amgen and AstraZeneca Present Groundbreaking Oncology Data at ESMO, Demonstrating a 58% Reduction in Risk of Death for Small Cell Lung Cancer

Amgen and AstraZeneca presented practice-changing Phase 3 clinical data at the European Society for Medical Oncology (ESMO) 2026 Congress,...

​Next-Generation MAKO 4 Robotic-Assisted Surgery System Officially Launched to Advance Precision in Joint Replacement

In a major development for orthopedic surgical technology, medical device innovators and surgical teams have celebrated the official rollout of...

​Indian Pharmacopoeia Commission Issues Drug Safety Alert Linking Levetiracetam and Topical Decongestants to Specific Adverse Reactions

The Indian Pharmacopoeia Commission (IPC), functioning as the National Coordination Centre for the Pharmacovigilance Programme of India (NCC-PvPI)...

Rising Yields Hit Sun Pharma’s Fundraising Drive as Bond Issue Misses ₹10,000 Crore Goal

India’s largest drugmaker by market capitalisation Sun Pharmaceutical Industries has raised ₹7,816 crore (~8000 cr) against its ₹10,000-crore fundraising target, highlighting the growing...